Christina Alves Peixoto Selected Research

Pleurisy (Pleuritis)

11/2014	Diethylcarbamazine inhibits NF-κB activation in acute lung injury induced by carrageenan in mice.
1/2014	Diethylcarbamazine attenuates the development of carrageenan-induced lung injury in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christina Alves Peixoto Research Topics

Disease

24	Inflammation (Inflammations) 11/2023 - 08/2012
14	Neuroinflammatory Diseases 04/2024 - 11/2012
6	Neoplasms (Cancer) 03/2024 - 01/2015
6	Demyelinating Diseases (Demyelinating Disease) 01/2023 - 11/2012
6	Type 2 Diabetes Mellitus (MODY) 12/2021 - 01/2015
5	Body Weight (Weight, Body) 04/2024 - 01/2014
5	Neurodegenerative Diseases (Neurodegenerative Disease) 02/2020 - 11/2012
5	Pulmonary Hypertension 10/2017 - 08/2009
4	Gliosis 09/2023 - 01/2016
4	Filarial Elephantiasis (Lymphatic Filariasis) 02/2017 - 11/2006
3	Multiple Sclerosis 01/2023 - 01/2015
3	Parkinson Disease (Parkinson's Disease) 10/2022 - 01/2015
3	Atherosclerosis 01/2018 - 01/2012
2	Dysbiosis 04/2024 - 01/2020
2	Papillomavirus Infections 08/2023 - 01/2022
2	Leukemia 09/2022 - 01/2021
2	Metabolic Diseases (Metabolic Disease) 12/2021 - 01/2020
2	Alzheimer Disease (Alzheimer's Disease) 09/2021 - 01/2015
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2021 - 08/2020
2	Cognitive Dysfunction 01/2021 - 01/2020
2	Obesity 01/2020 - 01/2018
2	Fibrosis (Cirrhosis) 11/2018 - 01/2014
2	Liver Cirrhosis (Hepatic Cirrhosis) 11/2018 - 04/2018
2	Non-alcoholic Fatty Liver Disease 01/2018 - 01/2015
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2018 - 10/2015
2	Acute Lung Injury 02/2017 - 11/2014
2	Liver Diseases (Liver Disease) 04/2015 - 04/2010
2	Erectile Dysfunction 12/2014 - 12/2009
2	Pleurisy (Pleuritis) 11/2014 - 01/2014
1	Uterine Cervical Dysplasia 08/2023
1	Infections 08/2023
1	Aneuploidy (Aneuploid) 01/2022
1	Dementia (Dementias) 09/2021
1	Amyloid Plaque 09/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Colorectal Neoplasms (Colorectal Cancer) 01/2021
1	Mania (Manias) 01/2021
1	Bipolar Disorder (Manic Depressive Psychosis) 01/2021
1	Hyperammonemia 02/2020
1	Depressive Disorder (Melancholia) 01/2020
1	Arthritis (Polyarthritis) 01/2020
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2019

Drug/Important Bio-Agent (IBA)

12	Diethylcarbamazine (Hetrazan)FDA Link 11/2018 - 11/2006
11	Sildenafil Citrate (Viagra)FDA Link 01/2021 - 08/2009
6	CytokinesIBA 01/2023 - 11/2012
6	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2016 - 08/2009
5	Metformin (Glucophage)FDA LinkGeneric 10/2022 - 01/2016
4	PrebioticsIBA 04/2024 - 01/2020
4	Neuroprotective AgentsIBA 01/2021 - 01/2013
4	CuprizoneIBA 01/2016 - 11/2012
3	Insulin (Novolin)FDA Link 04/2024 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 08/2023 - 01/2015
3	Phosphodiesterase 5 InhibitorsIBA 01/2021 - 08/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2020 - 01/2015
3	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 09/2019 - 07/2014
3	CollagenIBA 11/2018 - 01/2015
3	Carbon Tetrachloride (Tetrachloromethane)IBA 11/2018 - 01/2014
2	HLA-G Antigens (HLA G)IBA 08/2023 - 06/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 10/2019
2	Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA 02/2020 - 01/2015
2	Interleukin-10 (Interleukin 10)IBA 10/2019 - 06/2018
2	InterleukinsIBA 09/2019 - 04/2015
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 01/2015
2	NF-kappa B (NF-kB)IBA 01/2019 - 01/2016
2	SolutionsIBA 05/2018 - 10/2017
2	LipidsIBA 01/2018 - 04/2010
2	LipopolysaccharidesIBA 11/2016 - 01/2016
2	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 04/2015 - 07/2014
2	CarrageenanIBA 11/2014 - 01/2014
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2012 - 04/2010
1	Blood Glucose (Blood Sugar)IBA 04/2024
1	Acetates (Acetic Acid Esters)FDA Link 04/2024
1	Triglycerides (Triacylglycerol)IBA 04/2024
1	CholesterolIBA 04/2024
1	Immune Checkpoint ProteinsIBA 03/2024
1	Caspase 3 (Caspase-3)IBA 09/2023
1	fructooligosaccharideIBA 09/2023
1	IronIBA 01/2023
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023
1	ThiosemicarbazonesIBA 09/2022
1	1,2-naphthoquinoneIBA 09/2022
1	beta-lapachoneIBA 09/2022
1	transporter associated with antigen processing (TAP)IBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Fluoxetine (Prozac)FDA LinkGeneric 01/2022
1	Glucose (Dextrose)FDA LinkGeneric 12/2021
1	BiguanidesIBA 09/2021
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2021
1	Cytotoxins (Cytolysins)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	NigericinIBA 01/2021
1	Dextroamphetamine (Dexedrine)FDA LinkGeneric 01/2021
1	Doxycycline (Periostat)FDA LinkGeneric 01/2021
1	LithiumIBA 01/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 01/2021
1	Guanosine Monophosphate (5' Guanylic Acid)IBA 02/2020
1	CarbohydratesIBA 01/2020

Therapy/Procedure

3	Therapeutics 01/2022 - 12/2014
3	Injections 05/2018 - 01/2014
3	Oral Administration 04/2015 - 11/2012